TY - JOUR AU - QIN Zheng-hong AU - WANG Jin AU - GU Zhen-lun PY - 2016 TI - Development of novel therapies for Huntington’s disease: hope and challenge JF - Acta Pharmacologica Sinica; Vol 26, No 2 (February 2005): Acta Pharmacologica Sinica Y2 - 2016 KW - N2 - Huntington’s disease (HD) is an autosomal dominant neurological disease. It is a fatal neurological disorder affecting 5–10 out of 10 000 people. While there are intensive research efforts focusing on uncovering molecular mechanisms of the pathogenesis of HD, a number of studies have begun to look for effective therapies for HD. There is a large body of encouraging news on novel therapeutic developments. The present paper reviews drugs used for symptomatic treatment of HD and experimental therapies targeting HD molecular pathology. UR - http://www.chinaphar.com/article/view/3537